Cleared Traditional

Atellica IM Thyroglobulin (Tg)

Jun 2025
Decision
267d
Days
Class 2
Risk

About This 510(k) Submission

K242981 is an FDA 510(k) clearance for the Atellica IM Thyroglobulin (Tg), a System, Test, Thyroglobulin (Class II — Special Controls, product code MSW), submitted by Siemens Healthcare Diagnostics, Inc. (New York, US). The FDA issued a Cleared decision on June 20, 2025, 267 days after receiving the submission on September 26, 2024. This device falls under the Immunology review panel. Regulated under 21 CFR 866.6010.

Submission Details

510(k) Number K242981 FDA.gov
FDA Decision Cleared SESE
Date Received September 26, 2024
Decision Date June 20, 2025
Days to Decision 267 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code MSW — System, Test, Thyroglobulin
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.6010

Similar Devices — MSW System, Test, Thyroglobulin

All 12
Access Thyroglobulin
K240927 · Beckman Coulter, Inc. · Jun 2024
Access Thyroglobulin
K241423 · Beckman Coulter, Inc. · Jun 2024
Elecsys Tg II
K221890 · Roche Diagnostics · Sep 2023
Access Thyroglobulin
K220972 · Beckman Coulter, Inc. · Sep 2023
ACCESS THYROGLOBULIN REAGENTS ON THE ACCESS IMMUNOASSAY SYSTEMS
K031269 · Beckman Coulter, Inc. · May 2003
BRAHMS DIAGNOSTICA DYNOTEST TG-PLUS
K021057 · Brahms Diagnostica, LLC · Sep 2002